Efficacy and Toxicity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

被引：0
|
作者：
De Divitiis, C. [1 ]
Ottaiano, A. [1 ]
Capozzi, M. [1 ]
Von Arx, C. [2 ]
Faggiano, A. [3 ]
Di Sarno, A. [4 ]
Tatangelo, F. [1 ]
Modica, R. [3 ]
Bianco, A. [4 ]
De Cicco, F. [3 ]
Colao, A. [3 ]
Tafuto, S. [1 ]
机构：
[1] Ist Nazl Tumori Fond G Pascale, Naples, Italy
[2] Imperial Coll, London, England
[3] Univ Naples Federico II, Naples, Italy
[4] AO Colli Monaldi Unit, Naples, Italy
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
neuroendocrine tumors; chemotherapy; temozolomide; metronomic treatment; second-line;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H08
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] Efficacy of Axitinib as Second-line Treatment in Locally Advanced and Metastatic Renal Cell Carcinoma
    Ueda, Kosuke
    Suekane, Shigetaka
    Hirano, Taishi
    Ogasawara, Naoyuki
    Chikui, Katsuaki
    Uemura, Keiichiro
    Nakiri, Makoto
    Nishihara, Kiyoaki
    Matsuo, Mitsunori
    Igawa, Tsukasa
    ANTICANCER RESEARCH, 2018, 38 (09) : 5387 - 5392
  • [32] Efficacy and Safety of Capecitabine and Oxaliplatin Combination as Second-Line Treatment in Advanced Colorectal Cancer
    Heras, Panagiotis
    Kritikos, Konstantinos
    Hatzopoulos, Antonios
    Xourafas, Vasihos
    Kritikos, Nikolaos
    Karagiannis, Stefanos
    Mitsibounas, Dimitrios
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (04) : 319 - 322
  • [33] Efficacy and adverse reactions of apatinib as second-line or later-line treatment in advanced lung cancer
    Tao Ren
    Yan Wu
    Oncology and Translational Medicine, 2021, 7 (04) : 160 - 164
  • [34] The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer
    Naito, Renato
    Izumi, Kouji
    Kadomoto, Suguru
    Makino, Tomoyuki
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Kadono, Yoshifumi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1141 - 1146
  • [35] Efficacy of nivolumab and temozolomide in advanced neuroendocrine neoplasms (NENs) in a phase 2 clinical trial.
    Owen, Dwight Hall
    Benner, Brooke
    Wei, Lai
    Sukrithan, Vineeth
    Goyal, Ashima
    Zhou, Ye
    Suffren, Sheryl-Ann
    Pilcher, Carly
    Christenson, Gwen
    Curtis, Nancy
    Savardekar, Himanshu
    Norman, Ruthann
    Ferguson, Sarah
    Kleiber, Barbara
    Wesolowski, Robert
    Carson, William Edgar
    Otterson, Gregory Alan
    Verschraegen, Claire F.
    Shah, Manisha H.
    Konda, Bhavana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis
    Lewis, SJ
    Ainslie, GM
    Bateman, ED
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 1999, 16 (01) : 87 - 92
  • [37] An Italian multi-center phase II trial of Metronomic Temozolomide in unfit patients with advanced neuroendocrine neoplasms: MeTe study
    Spada, F.
    Jemos, C.
    Pisa, E.
    Bagnardi, V
    Frassoni, S.
    Boselli, S.
    Mazzon, C.
    Rossi, M.
    Gelsomino, F.
    Gervaso, L.
    Benini, L.
    Fazio, N.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 249 - 249
  • [38] Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
    Thomas, Katharine
    Voros, Brianne A.
    Meadows-Taylor, Meghan
    Smeltzer, Matthew P.
    Griffin, Ryan
    Boudreaux, J. Philip
    Thiagarajan, Ramcharan
    Woltering, Eugene A.
    Ramirez, Robert A.
    CANCERS, 2020, 12 (01)
  • [39] Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma
    Yuko Iida
    Kazushige Wakuda
    Hirotsugu Kenmotsu
    Kosei Doshita
    Hiroaki Kodama
    Naoya Nishioka
    Eriko Miyawaki
    Taichi Miyawaki
    Nobuaki Mamesaya
    Haruki Kobayashi
    Shota Omori
    Ryo Ko
    Akira Ono
    Tateaki Naito
    Haruyasu Murakami
    Takashi Sugino
    Yasuhiro Gon
    Toshiaki Takahashi
    Scientific Reports, 14
  • [40] Capecitabine and temozolomide in advanced neuroendocrine neoplasms - A single center experience
    Monteiro, J.
    Caetano, A. C.
    Pires, M.
    Costa, C.
    Elvas, A. R.
    Couto, J.
    Martins, R.
    Ribeiro, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 180 - 180
12345